Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin.

Yamaguchi M, Suzuki R, Miyazaki K, Amaki J, Takizawa J, Sekiguchi N, Kinoshita S, Tomita N, Wada H, Kobayashi Y, Niitsu N, Ando T, Maeda T, Saito B, Matsuoka H, Sakai R, Kubota N, Masaki Y, Kameoka Y, Asano N, Oguchi M, Katayama N.

Ann Hematol. 2019 Apr 19. doi: 10.1007/s00277-019-03689-9. [Epub ahead of print]

PMID:
31001658
2.

NM23 downregulation and lysophosphatidic acid receptor EDG2/lpa1 upregulation during myeloid differentiation of human leukemia cells.

Okabe-Kado J, Hagiwara-Watanabe Y, Niitsu N, Kasukabe T, Kaneko Y.

Leuk Res. 2018 Mar;66:39-48. doi: 10.1016/j.leukres.2018.01.003. Epub 2018 Jan 3.

PMID:
29407582
3.

Lymphocyte-Rich Classical Hodgkin Lymphoma. A Case with Difficulty in Distinguishing from Nodular Lymphocyte-Predominant Hodgkin Lymphoma.

Sakai J, Tanae K, Takahashi N, Nagata K, Yoshino T, Tamaru J, Niitsu N.

J Clin Exp Hematop. 2015;55(1):23-8. doi: 10.3960/jslrt.55.23.

5.

Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma.

Tateishi U, Tatsumi M, Terauchi T, Ando K, Niitsu N, Kim WS, Suh C, Ogura M, Tobinai K.

Cancer Sci. 2015 Feb;106(2):186-93. doi: 10.1111/cas.12588. Epub 2015 Feb 4.

6.

Communication: Two-step explosion processes of highly charged fullerene cations C60(q+) (q = 20-60).

Yamazaki K, Nakamura T, Niitsu N, Kanno M, Ueda K, Kono H.

J Chem Phys. 2014 Sep 28;141(12):121105. doi: 10.1063/1.4896656. Erratum in: J Chem Phys. 2014 Dec 28;141(24):249904.

PMID:
25273405
7.

Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan.

Aoki T, Izutsu K, Suzuki R, Nakaseko C, Arima H, Shimada K, Tomita A, Sasaki M, Takizawa J, Mitani K, Igarashi T, Maeda Y, Fukuhara N, Ishida F, Niitsu N, Ohmachi K, Takasaki H, Nakamura N, Kinoshita T, Nakamura S, Ogura M.

Haematologica. 2014 Dec;99(12):1817-25. doi: 10.3324/haematol.2014.111203. Epub 2014 Sep 12.

8.

[Targeted therapy].

Niitsu N.

Nihon Rinsho. 2014 Mar;72(3):473-7. Japanese.

PMID:
24724406
9.

Incidence and clinical significance of aberrant T-cell marker expression on diffuse large B-cell lymphoma cells.

Suzuki Y, Yoshida T, Wang G, Aoki T, Katayama T, Miyamoto S, Miyazaki K, Iwabuchi K, Danbara M, Nakayama M, Horie R, Nakamine H, Sato Y, Nakamura N, Niitsu N.

Acta Haematol. 2013;130(4):230-7. doi: 10.1159/000348550. Epub 2013 Jun 26.

10.

Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma.

Ohmachi K, Niitsu N, Uchida T, Kim SJ, Ando K, Takahashi N, Takahashi N, Uike N, Eom HS, Chae YS, Terauchi T, Tateishi U, Tatsumi M, Kim WS, Tobinai K, Suh C, Ogura M.

J Clin Oncol. 2013 Jun 10;31(17):2103-9. doi: 10.1200/JCO.2012.46.5203. Epub 2013 May 6.

PMID:
23650408
11.

[Treatment of patients with relapsed or refractory diffuse large B-cell lymphoma].

Niitsu N.

Nihon Rinsho. 2012 Apr;70 Suppl 2:509-13. Japanese. No abstract available.

PMID:
23134007
12.

Electronic excited state paths of Stone-Wales rearrangement in pyrene: roles of conical intersections.

Yamazaki K, Niitsu N, Nakamura K, Kanno M, Kono H.

J Phys Chem A. 2012 Nov 26;116(46):11441-50. doi: 10.1021/jp306894x. Epub 2012 Oct 16.

PMID:
22994422
13.

Nanosecond simulations of the dynamics of C60 excited by intense near-infrared laser pulses: impulsive Raman excitation, rearrangement, and fragmentation.

Niitsu N, Kikuchi M, Ikeda H, Yamazaki K, Kanno M, Kono H, Mitsuke K, Toda M, Nakai K.

J Chem Phys. 2012 Apr 28;136(16):164304. doi: 10.1063/1.4704896.

PMID:
22559479
14.

Association of CD20 levels with clinicopathological parameters and its prognostic significance for patients with DLBCL.

Suzuki Y, Yoshida T, Wang G, Togano T, Miyamoto S, Miyazaki K, Iwabuchi K, Nakayama M, Horie R, Niitsu N, Sato Y, Nakamura N.

Ann Hematol. 2012 Jul;91(7):997-1005. doi: 10.1007/s00277-012-1407-4. Epub 2012 Jan 17.

PMID:
22249209
15.

[Point of diagnosis and treatment of extranodal diffuse large B-cell lymphoma].

Niitsu N.

Rinsho Ketsueki. 2011 Oct;52(10):1637-44. Review. Japanese. No abstract available.

PMID:
21971241
16.

Cytotoxic molecule-positive classical Hodgkin's lymphoma: a clinicopathological comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type.

Asano N, Kinoshita T, Tamaru J, Ohshima K, Yoshino T, Niitsu N, Tsukamoto N, Hirabayashi K, Izutsu K, Taniwaki M, Morishima Y, Nakamura S.

Haematologica. 2011 Nov;96(11):1636-43. doi: 10.3324/haematol.2011.041079. Epub 2011 Aug 22.

17.

Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers.

Niitsu N, Hayama M, Yoshino T, Nakamura S, Tamaru J, Nakamine H, Okamoto M.

Br J Haematol. 2011 Jun;153(5):582-8. doi: 10.1111/j.1365-2141.2011.08634.x. Epub 2011 Apr 15.

PMID:
21492124
18.

Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma, not otherwise specified.

Niitsu N, Nakamine H, Okamoto M.

Clin Cancer Res. 2011 May 1;17(9):2893-9. doi: 10.1158/1078-0432.CCR-10-2999. Epub 2011 Apr 8.

19.

CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab.

Miyazaki K, Yamaguchi M, Suzuki R, Kobayashi Y, Maeshima AM, Niitsu N, Ennishi D, Tamaru JI, Ishizawa K, Kashimura M, Kagami Y, Sunami K, Yamane H, Nishikori M, Kosugi H, Yujiri T, Hyo R, Katayama N, Kinoshita T, Nakamura S.

Ann Oncol. 2011 Jul;22(7):1601-7. doi: 10.1093/annonc/mdq627. Epub 2011 Jan 3.

PMID:
21199885
20.

Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy.

Niitsu N, Hagiwara Y, Tanae K, Kohri M, Takahashi N.

J Clin Oncol. 2010 Dec 1;28(34):5097-100. doi: 10.1200/JCO.2010.29.7531. Epub 2010 Sep 13. Retraction in: J Clin Oncol. 2011 Sep 20;29(27):3720.

PMID:
20837949
21.

Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis.

Ennishi D, Maeda Y, Niitsu N, Kojima M, Izutsu K, Takizawa J, Kusumoto S, Okamoto M, Yokoyama M, Takamatsu Y, Sunami K, Miyata A, Murayama K, Sakai A, Matsumoto M, Shinagawa K, Takaki A, Matsuo K, Kinoshita T, Tanimoto M.

Blood. 2010 Dec 9;116(24):5119-25. doi: 10.1182/blood-2010-06-289231. Epub 2010 Sep 7.

22.

A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy.

Niitsu N, Tamaru J, Yoshino T, Nakamura N, Nakamura S, Ohshima K, Nakamine H, Okamoto M.

Ann Hematol. 2011 Feb;90(2):185-92. doi: 10.1007/s00277-010-1060-8. Epub 2010 Sep 1.

PMID:
20809421
23.

Current treatment strategy of diffuse large B-cell lymphomas.

Niitsu N.

Int J Hematol. 2010 Sep;92(2):231-7. doi: 10.1007/s12185-010-0666-x. Epub 2010 Aug 28. Review.

PMID:
20803108
24.

CD3- and CD4-positive plasmablastic lymphoma: a literature review of Japanese plasmablastic lymphoma cases.

Suzuki Y, Yoshida T, Nakamura N, Kamata H, Kotani S, Ohsaka M, Kajita S, Miyazaki K, Ohtani S, Nakayama M, Horie R, Hayakawa K, Niitsu N, Higashihara M.

Intern Med. 2010;49(16):1801-5. Epub 2010 Aug 13. Review.

25.

Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells.

Hagiwara Y, Kasukabe T, Kaneko Y, Niitsu N, Okabe-Kado J.

Int J Hematol. 2010 Jul;92(1):136-43. doi: 10.1007/s12185-010-0627-4. Epub 2010 Jun 18.

PMID:
20559758
26.

Central nervous system involvement in intravascular large B-cell lymphoma: a retrospective analysis of 109 patients.

Shimada K, Murase T, Matsue K, Okamoto M, Ichikawa N, Tsukamoto N, Niitsu N, Miwa H, Asaoku H, Kosugi H, Kikuchi A, Matsumoto M, Saburi Y, Masaki Y, Yamamoto K, Yamaguchi M, Nakamura S, Naoe T, Kinoshita T; IVL Study Group in Japan.

Cancer Sci. 2010 Jun;101(6):1480-6. doi: 10.1111/j.1349-7006.2010.01555.x. Epub 2010 Mar 6.

27.

[Marfan syndrome complicated with CD5+ CD10+ diffuse large B-cell lymphoma].

Yoshitake K, Hagiwara Y, Tanae K, Takahashi N, Kohri M, Tamaru J, Bessho M, Niitsu N.

Rinsho Ketsueki. 2010 Mar;51(3):196-200. Japanese.

PMID:
20379114
28.

Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B-cell lymphoma.

Niitsu N, Kohri M, Hagiwara Y, Tanae K, Takahashi N, Bessho M, Okamoto M.

Hematol Oncol. 2010 Jun;28(2):68-74. doi: 10.1002/hon.940.

PMID:
20235332
29.

Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma.

Niitsu N, Okamoto M, Tamaru JI, Yoshino T, Nakamura N, Nakamura S, Ohshima K, Nakamine H, Hirano M.

Ann Oncol. 2010 Oct;21(10):2069-74. doi: 10.1093/annonc/mdq057. Epub 2010 Mar 15.

PMID:
20231297
30.

Clinicopathologic correlations of diffuse large B-cell lymphoma in rheumatoid arthritis patients treated with methotrexate.

Niitsu N, Okamoto M, Nakamine H, Hirano M.

Cancer Sci. 2010 May;101(5):1309-13. doi: 10.1111/j.1349-7006.2010.01517.x. Epub 2010 Jan 28.

31.

Primary cutaneous anaplastic large-cell lymphoma presenting with hemophagocytic syndrome: a case report and review of the literature.

Shimizu Y, Tanae K, Takahashi N, Kohri M, Arai E, Bessho M, Niitsu N.

Leuk Res. 2010 Feb;34(2):263-6. doi: 10.1016/j.leukres.2009.07.001. Epub 2009 Jul 28. Review.

PMID:
19640585
32.

[Peripheral T cell lymphoma].

Niitsu N.

Gan To Kagaku Ryoho. 2009 May;36(5):752-5. Japanese. No abstract available.

PMID:
19496284
33.

Lymphoproliferative disorders after immunosuppressive therapy for aplastic anemia: a case report and literature review.

Suzuki Y, Niitsu N, Hayama M, Katayama T, Ishii R, Osaka M, Miyazaki K, Danbara M, Horie R, Yoshida T, Nakamura N, Higashihara M.

Acta Haematol. 2009;121(1):21-6. doi: 10.1159/000209225. Epub 2009 Mar 18. Review.

PMID:
19295190
34.

Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations.

Niitsu N, Okamoto M, Miura I, Hirano M.

Leukemia. 2009 Apr;23(4):777-83. doi: 10.1038/leu.2008.344. Epub 2009 Jan 8.

PMID:
19151788
35.

Alveolar rhabdomyosarcoma mimicking nasal lymphoma at the initial presentation.

Ihara T, Okamura D, Takahashi N, Kohri M, Kayano H, Tamaru J, Niitsu N.

J Clin Exp Hematop. 2008 Nov;48(2):61-4.

36.

Renal intravascular large B-cell lymphoma with early diagnosis by renal biopsy: a case report and review of the literature.

Niitsu N, Okamura D, Takahashi N, Tanae K, Hagiwara Y, Kayano H, Bessho M.

Leuk Res. 2009 May;33(5):728-30. doi: 10.1016/j.leukres.2008.10.019. Epub 2008 Nov 25.

PMID:
19036442
37.

ALK-positive anaplastic large cell lymphoma with dic(2;4)(p23;q33).

Niitsu N, Kohri M, Hayama M, Tamaru J, Miura I.

Leuk Res. 2009 Jun;33(6):e23-5. doi: 10.1016/j.leukres.2008.09.038. Epub 2008 Nov 25. No abstract available.

PMID:
19036440
38.

[Malignant lymphoma. Physiopathology and therapy. 3. Diffuse large B-cell lymphoma].

Niitsu N.

Nihon Naika Gakkai Zasshi. 2008 Jul 10;97(7):1588-94. Japanese. No abstract available.

PMID:
18720600
39.

A clinicopathological study of nm23-H1 expression in classical Hodgkin's lymphoma.

Niitsu N, Nakamine H, Okamoto M, Tamaru JI, Hirano M.

Ann Oncol. 2008 Nov;19(11):1941-6. doi: 10.1093/annonc/mdn413. Epub 2008 Jul 22.

PMID:
18647967
40.

Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan.

Shimada K, Matsue K, Yamamoto K, Murase T, Ichikawa N, Okamoto M, Niitsu N, Kosugi H, Tsukamoto N, Miwa H, Asaoku H, Kikuchi A, Matsumoto M, Saburi Y, Masaki Y, Yamaguchi M, Nakamura S, Naoe T, Kinoshita T.

J Clin Oncol. 2008 Jul 1;26(19):3189-95. doi: 10.1200/JCO.2007.15.4278. Epub 2008 May 27.

PMID:
18506023
41.

Clinicopathologic features and treatment outcome of primary breast diffuse large B-cell lymphoma.

Niitsu N, Okamoto M, Nakamine H, Hirano M.

Leuk Res. 2008 Dec;32(12):1837-41. doi: 10.1016/j.leukres.2008.04.005. Epub 2008 May 19.

PMID:
18490056
42.

The GAS5 (growth arrest-specific transcript 5) gene fuses to BCL6 as a result of t(1;3)(q25;q27) in a patient with B-cell lymphoma.

Nakamura Y, Takahashi N, Kakegawa E, Yoshida K, Ito Y, Kayano H, Niitsu N, Jinnai I, Bessho M.

Cancer Genet Cytogenet. 2008 Apr 15;182(2):144-9. doi: 10.1016/j.cancergencyto.2008.01.013.

PMID:
18406879
43.

Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas.

Niitsu N, Okamoto M, Nakamine H, Aoki S, Motomura S, Hirano M.

Hematol Oncol. 2008 Sep;26(3):152-8. doi: 10.1002/hon.853.

PMID:
18395866
44.

t(6;14)(q15;q32) in a patient with CD5+CD10+ diffuse large B-cell lymphoma.

Hayama M, Niitsu N, Higashihara M, Nakamine H, Miura I.

Int J Hematol. 2007 Aug;86(2):147-9.

PMID:
17875529
45.

The t(1;3)(p34;q27) translocation: a nonrandom BCL6 rearrangement in diffuse large B cell lymphoma.

Niitsu N, Nakamine H, Hagiwara Y, Tanae K, Miura I.

Ann Hematol. 2008 Feb;87(2):151-3. Epub 2007 Jul 26. No abstract available.

PMID:
17653714
46.

Successful radiotherapy in a patient with primary rectal mucosa-associated lymphoid tissue lymphoma without the API2-MALT1 fusion gene: a case report and review of the literature.

Kobayashi T, Takahashi N, Hagiwara Y, Tamaru J, Kayano H, Jin-nai I, Bessho M, Niitsu N.

Leuk Res. 2008 Jan;32(1):173-5. Epub 2007 Jun 13. Review.

PMID:
17570523
47.

[The stratification treatment that was based on a prognostic factor of malignant lymphoma].

Niitsu N.

Nihon Rinsho. 2007 Jan 28;65 Suppl 1:534-9. Review. Japanese. No abstract available.

PMID:
17476756
48.

Clinicopathologic correlations of stage IE/IIE primary thyroid diffuse large B-cell lymphoma.

Niitsu N, Okamoto M, Nakamura N, Nakamine H, Bessho M, Hirano M.

Ann Oncol. 2007 Jul;18(7):1203-8. Epub 2007 Apr 11.

PMID:
17429099
49.

Prognostic impact of chromosomal alteration of 3q27 on nodal B-cell lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 329 consecutive patients.

Niitsu N, Okamoto M, Nakamura N, Nakamine H, Aoki S, Hirano M, Miura I.

Leuk Res. 2007 Sep;31(9):1191-7. Epub 2007 Jan 2.

PMID:
17197022
50.

Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma.

Niitsu N, Okamoto M, Tomita N, Aoki S, Tamaru J, Miura I, Hirano M.

Leuk Lymphoma. 2006 Sep;47(9):1908-14.

PMID:
17065005

Supplemental Content

Loading ...
Support Center